Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Triple-negative breast cancer: understanding Wnt signaling in drug resistance

10 Aug 2021

Abstract excerpt

Triple-negative breast cancer (TNBC) is not as prevalent as hormone receptor or HER2-positive breast cancers and all receptor tests come back negative. More importantly, the heterogeneity and complexity of the TNBC on the molecular and clinical levels have limited the successful development of novel therapeutic strategies and led to intrinsic or developed resistance to chemotherapies and new therapeutic agents....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Cells and Metastasis
Share to HER2/EGFR in Cancer Research
Share to Wnt/β-catenin signaling in development and cancer

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 34376211
DOI: 10.1186/s12935-021-02107-3

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Triple-negative breast cancer: understanding Wnt signaling in drug resistancePMID 34376211Read ↗

Wnt signaling in triple negative breast cancer is associated with metastasisSemantic proximity Read ↗

Advances in the Understanding of the Pathogenesis of Triple-Negative Breast Cancer.Semantic proximity Read ↗

Wnt/β-catenin inhibition disrupts drug-tolerance in isogenic carboplatin-resistant models of Triple-Negative Breast CancerSemantic proximity Read ↗

Wnt signaling in cancer: from biomarkers to targeted therapies and clinical translationSemantic proximity Read ↗

Wnt/β‑catenin signaling: Causes and treatment targets of drug resistance in colorectal cancer (Review)Semantic proximity Read ↗

Wnt signaling promotes inflammation and EMT-associated gene expression in mesenchymal TNBCSemantic proximity Read ↗

Wnt Signaling and Drug Resistance in Cancer.Semantic proximity Read ↗

Expression of Wnt3 activates Wnt/β-catenin pathway and promotes EMT-like phenotype in trastuzumab-resistant HER2-overexpressing breast cancer cells.Semantic proximity Read ↗

Investigating the Expression Pattern, Prognostic and Immunological Significance of the WNT family in Breast CancerSemantic proximity Read ↗

Harnessing AI to Reveal CTNNB1’s Central Role in Breast Cancer Progression and Drug DiscoverySemantic proximity Read ↗

Wnt-beta-catenin pathway signals metastasis-associated tumor cell phenotypes in triple negative breast cancers.Semantic proximity Read ↗

lncRNA-WAL Promotes Aggressiveness of Triple-Negative Breast Cancer via inducing β-Catenin nuclear translocationSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.